np event 2254995 0E193A 1 1
Oct 2, 2026
Improving Outcomes with Targeted FcRn Receptor Inhibition for the Full Spectrum of Patients with gMG
Satellite Symposium at the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting

Date/Time

Friday, October 2nd
from 7:00am – 8:00am EDT

Location

Signia by Hilton Orlando Bonnet Creek | Grand Ballroom
14100 Bonnet Creek Resort Ln
Orlando, FL 32821

To join this virtual session, please utilize the following link: TBD

Who Should Attend

Neuromuscular disease specialists, general neurologists, their expanded care teams, and other healthcare providers who contribute to the management of patients with gMG.

Accreditation Statement

Joint

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AcademicCME designates this live material for a maximum of 1.0 AMA PRA Category 1 CreditTM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Financial Support

This activity is supported by an independent educational from argenx.

This activity will be held during the AANEM Annual Meeting. It is not part of the official scientific program of the AANEM.

Faculty

Howard Headshot  e1721236596371
James F. Howard Jr., MD
Professor of Neurology, Medicine & Allied Health
Director, Myasthenia Gravis Clinical Trials and Translational Research Program
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
HABIB
Ali A. Habib, MD
Clinical Professor
Director, Neuromuscular Medicine Fellowship
Department of Neurology
University of California, Irvine
Irvine, California
Pushpa Narayanaswami, MD, FAAN
Pushpa Narayanaswami, MD, FAAN
Professor of Clinical Neurology
Harvard Medical School
Vice Chair, Clinical Operations
Department of Neurology
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Event Details

CE Inquiries/Special Needs

Provided by

AcademicLogo
1

Review the current standards of care, diagnostics, serotyping, current therapeutic landscape, and unmet needs of adolescent patients with gMG.

2

Discuss current clinical trial data for FcRn receptor blockers for patients with gMG.

3

Discuss strategies for developing individualized treatment plans to manage patients with all AChR-Ab seronegative gMG subtypes.

4

Analyze lessons learned from real world data in the management of gMG to minimize glucocorticoid use, address safety concerns, optimize patient adherence, and improve
long term outcomes.

Faculty

Howard Headshot  e1721236596371
James F. Howard Jr., MD
Professor of Neurology, Medicine & Allied Health
Director, Myasthenia Gravis Clinical Trials and Translational Research Program
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
HABIB
Ali A. Habib, MD
Clinical Professor
Director, Neuromuscular Medicine Fellowship
Department of Neurology
University of California, Irvine
Irvine, California
Pushpa Narayanaswami, MD, FAAN
Pushpa Narayanaswami, MD, FAAN
Professor of Clinical Neurology
Harvard Medical School
Vice Chair, Clinical Operations
Department of Neurology
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Signia by Hilton Orlando Bonnet Creek | Grand Ballroom
14100 Bonnet Creek Resort Ln
Orlando, FL 32821

To join this virtual session, please utilize the following link: TBD

Event Registration

Related Upcoming Events

CME Symposium at the 2026 Eastern Pulmonary Conference
September 13, 2026
Pulmonology
CME Symposium at the 2026 Eastern Pulmonary Conference
September 13, 2026
Pulmonology